15 July 2022 | Friday | News
Image Source : Public Domain
A life sciences entrepreneur and seasoned global commercial executive, Wilbur brings nearly 30 years of experience building businesses, developing high-performance teams and scaling commercial organizations to drive growth and customer success.
"Jim's deep experience driving commercial excellence and execution at scale make him the ideal person to lead our global commercial team in this next phase of growth," said Serge Saxonov, Co-founder and CEO of 10x Genomics. "What stood out from all the other great candidates is Jim's detailed understanding and passion of the sales craft, his ability to operate strategically from first principles and his technical depth as a top-notch scientist. It's an incredibly rare combination. He is a great fit with the 10x mission and culture, is rigorous about process and data and has tremendous energy to get things done. We're thrilled to welcome him to the team."
Wilbur joins 10x Genomics from Meso Scale Discovery (MSD), the world's leading provider of highly sensitive multiplex immunoassays. Widely recognized for its innovative and robust technology, MSD develops, manufactures and markets instruments and assays for research use in life sciences and biodefense.
As part of the original team that started the operations of MSD, Wilbur initially led the development of the company's core technology and products. When MSD launched its first products in 2001, Wilbur assumed leadership for the company's commercial function, building the global team responsible for marketing, selling and servicing the company's portfolio of instruments and consumables. Since that time, Wilbur has scaled MSD's global commercial organization to deliver sustained high growth and cultivate deep partnerships with customers.
"It's an exciting time to join the 10x team, be part of the company's mission and have the opportunity to make a difference in a transformational way," said Wilbur. "10x has a great foundation to build on, and I have strong confidence in the company's long-term opportunity and ability to fulfill the tremendous promise of single cell and spatial biology. I look forward to helping the team drive a strong culture of commercial excellence, deliver meaningful value for customers and accelerate growth and impact."
Wilbur earned his bachelor's degree in chemistry and intellectual history from the University of California, San Diego, and holds his Ph.D. in chemistry from Stanford University. Prior to MSD, he completed an NIH Postdoctoral Fellowship at Harvard University.